Asterion (Drug Discovery) Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Asterion (Drug Discovery) General Information

Description

Developer of a novel therapeutic drug designed to help in the treatment of serious chronic and acute disorders. The company's drug is made by applying engineering techniques that have long-acting potent biopharmaceuticals that require frequent administration than existing marketed drugs, enabling patients to have improved healthcare outcomes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • The Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom
+44 0114
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • The Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom
+44 0114

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asterion (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 14-Sep-2021 Completed Out of Business
5. Secondary Transaction - Private 01-Jun-2020 Completed Generating Revenue
4. Later Stage VC 26-Mar-2008 Completed Generating Revenue
3. Later Stage VC 12-May-2006 Completed Generating Revenue
2. Later Stage VC 01-May-2006 Completed Startup
1. Seed Round 01-Feb-2001 Completed Startup
To view Asterion (Drug Discovery)’s complete valuation and funding history, request access »

Asterion (Drug Discovery) Patents

Asterion (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201520021-D0 Fusion polypeptide Inactive 13-Nov-2015
GB-201617799-D0 Fusion polypeptide Inactive 13-Nov-2015
GB-201713537-D0 Fusion polypeptide Inactive 13-Nov-2015
GB-2549351-A Fusion polypeptide Inactive 13-Nov-2015
GB-2550792-A Fusion polypeptide Inactive 13-Nov-2015 C07K14/535
To view Asterion (Drug Discovery)’s complete patent history, request access »

Asterion (Drug Discovery) FAQs

  • When was Asterion (Drug Discovery) founded?

    Asterion (Drug Discovery) was founded in 2000.

  • Where is Asterion (Drug Discovery) headquartered?

    Asterion (Drug Discovery) is headquartered in Sheffield, United Kingdom.

  • What industry is Asterion (Drug Discovery) in?

    Asterion (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Asterion (Drug Discovery) a private or public company?

    Asterion (Drug Discovery) is a Private company.

  • What is Asterion (Drug Discovery)’s current revenue?

    The current revenue for Asterion (Drug Discovery) is .

  • How much funding has Asterion (Drug Discovery) raised over time?

    Asterion (Drug Discovery) has raised $1.18M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process